Accelerating Drug Discovery with Synthetic Biology

eBook: Accelerating Drug Discovery with Synthetic Biology

Although technological and automation advancements have helped accelerate antibody discovery, the development of complex antibody-based drugs and therapeutics remains challenging. Synthetic biology has recently emerged as a way to break free of traditional bottlenecks and improve antibody discovery workflows.

This eBook explains how synthetic biology can be used to connect high-content sequencing data from B cell discovery platforms to downstream high-throughput antibody screening and characterization workflows to maintain consistent and high-throughput processes throughout discovery operations.

Topics covered in this eBook also include:

• Use of synthetic biology workflows to complete antibody cloning in days not weeks
• How to produce transfection-ready plasmids in a fraction of the time previously required
• Steps to take to accelerate lead identification
• The advantages of building scFv constructs using synthetic biology

Complete the adjacent form today for access to the eBook.